Atlas Trials

MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes

Clinical trial NCT04761900 · COMPLETED

Trial details

NCT number
NCT04761900
Sponsor
Ningbo No. 1 Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Metabolic Associated Fatty Liver Disease
Start date
2012-01-01
Primary completion
2019-12-31
Enrollment
3372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.